Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth to Use Genedata’s Software for Microarray Analysis

NEW YORK, (GenomeWeb News) - Genedata, an informatics company based in Basel, Switzerland, said today that Wyeth Pharmaceuticals has licensed its software to support its drug discovery efforts.
Genedata said it has integrated its Expressionist and Phylosopher software platforms with Wyeth’s informatics infrastructure to create new analysis portals, allowing researchers to “navigate large result repositories” and to “drill down” for information on data quality and experimental design.
Genedata said its solution offers a platform capable of analyzing “tens of thousands of microarrays per month.”
The company added that Wyeth’s “scientific business rules” have been integrated with Genedata’s analysis workflows.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.